Alger, Algérie ; 6 Février : General Electric a annoncé aujourd’hui l’ouverture de son centre de formation, GETLA (General Electric Technical and Leadership Academy), situé au sein de la Tour CMA CGM, dans le quartier d’affaires de Bab Ezzouar à Alger. S’étendant sur une surface de plus de 650 m², GETLA est le premier centre de formation... Read more
Roka Bioscience to Present at the International Association of Food Protection Conference WARREN, N.J., July 7, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA) will be participating and presenting at the 2017 International Association for Food Protection (IAFP) Conference. The conference will be held at the Tampa Convention Center in Tampa, Florida, from July 9th through July... Read more
On July 7, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) recommended to suspend broad spectrum intravenous use of linear gadolinium agents except for select indication of liver imaging. The PRAC’s recommendation applies to Europe only and is not https://www.genewsroom.com/press-releases/message-our-customers-about-pharmacovigilance-risk-assessment-committee Read more
Basel, 07 July 2017 Invitation to Roche Analyst Event at ISTH 2017 Monday, 10 July 2017, 6:30pm CEST Roche will host an analyst briefing during the International Society on Thrombosis and Hemostasis Congress (ISTH) in Berlin 8 – 13 July 2017. Meeting Information Date: Monday, 10 July 2017 Time: 6:00pm Registration desk opens 6:30pm Start... Read more
WALDBRONN, Germany, July 7, 2017 Agilent Technologies Inc. (NYSE: A), today celebrated the opening of a new Agilent Customer and Technology Center at the Agilent campus in Waldbronn, Germany. Agilent executives were accompanied at the event by Katrin Schütz, state secretary in the Ministry of Economic Affairs, Labor, and Housing for the state of Baden-Württemberg;... Read more
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 7, 2017– Agilent Technologies Inc. (NYSE:A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied... Read more
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif.–(BUSINESS WIRE)–Jul. 7, 2017– Agilent Technologies Inc. (NYSE:A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied... Read more
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers SANTA CLARA, Calif., July 7, 2017 Agilent Technologies Inc. (NYSE: A) today announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems (“Cobalt”), a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry,... Read more
АСТАНА, Казахстан, 07 июля 2017 г. – В рамках международной выставки ЭКСПО-2017 в Астане GE Healthcare и группа компаний «Медикер» подписали меморандум о взаимопонимании и стратегическом партнерстве. Документ предполагает сотрудничество в области проектирования и разработки комплексных решений в https://www.genewsroom.com/press-releases/ge-healthcare-%D0%B8-%D0%B3%D1%80%D1%83%D0%BF%D0%BF%D0%B0-%D0%BA%D0%BE%D0%BC%D0%BF%D0%B0%D0%BD%D0%B8%D0%B9-%C2%AB%D0%BC%D0%B5%D0%B4%D0%B8%D0%BA%D0%B5%D1%80%C2%BB-%D0%BF%D0%BE%D0%B4%D0%BF%D0%B8%D1%81%D0%B0%D0%BB%D0%B8-%D0%BC%D0%B5%D0%BC%D0%BE%D1%80%D0%B0%D0%BD%D0%B4%D1%83%D0%BC-%D0%BE-%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%B5%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%BC Read more
MADISON, WI USA (July 6, 2017) Promega Corporation intends to seek US Food and Drug Administration approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. MSI status is a measure of mismatch-repair deficiency commonly found in solid tumors. In addition to the colorectal... Read more